Jul 1, 2026 BPC-157 Before the FDA: Briefing Document Focuses on Ulcerative Colitis BPC-157 will be evaluated by the FDA's Pharmacy Compounding Advisory Committee on July 23, 2026
Growth Hormone Secretagogues and IGF-1 Analogs Growth hormone secretagogues, including CJC-1295, ipamorelin, and sermorelin, and IGF-1 analogs are increasingly used in wellness and optimization settings and are frequently co-administered with BPC-157 or TB-500 (Rahman et al
Research has found a link between tinnitus and vitamin deficiencies, especially in vitamins B12 and D
B2 Riboflavin: Boosts metabolism and supports the immune system
Section symposium, Honolulu, Hawaii, 13:032 Veljaca M, Sladoljev P, Mildner B (2003) Tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers